12:00 AM
Nov 09, 2009
 |  BC Week In Review  |  Financial News  |  Completed Offerings

GTC Biotherapeutics completes private placement of convertible preferred stock

GTC Biotherapeutics Inc. (NASDAQ:GTCB), Framingham, Mass.
Business: Biomanufacturing, Cardiovascular, Hematology
Date completed: 11/2/09...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >